*Read Disclaimer Sponsored Content
October 15, 2026 | Unsubscribe
Hello!
We wanted to give you a quick intraday update on our new alert, Modular Medical, Inc. (Nasdaq: MODD).
MODD opened today at 1.95 and so far rallied to a high of 2.20, up +12% this morning.
This could be just the beginning of a bigger breakout higher.
Currently, the 20 and 50-day moving averages sit at 2.25 and 2.63, +15% and +34% upside from today’s open.
A breakout and close above this level could present increased upside potential.
In addition, this morning, MODD announced breaking news that could be an added growth catalyst for the company.
Here is the news from this morning:
“Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System”
“Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in Identifying Candidates for Pump Adoption”
SAN DIEGO, CA / ACCESS Newswire / October 15, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced the launch of two innovative digital education resources designed to assist people living with diabetes build familiarity and confidence with insulin therapy ahead of formal training on the Pivot insulin delivery system.
As the company further explains:
“Developed in partnership with Relevate Health Games, the new tools use game-based technology to walk patients through the skills needed for insulin pump therapy. The resources are designed to help reduce barriers to adoption by allowing prospective users to become familiar with pump therapy before beginning formal onboarding. The first educational module gives users a virtual, hands-on walkthrough of the Pivot insulin delivery system. In approximately 15 minutes, users can visualize how to unpack the system, prepare and apply the pump, and understand the basic operational functions. The Pivot module was first previewed at the ADCES 2025 Annual Conference in August 2025.”
Here are some of the company’s comments from this press release:
"We believe one of the greatest barriers to insulin pump adoption is patient uncertainty," said Jeb Besser, Chief Executive Officer of Modular Medical. "Our Pivot pump was designed to simplify insulin delivery, and these new educational tools extend that approach by allowing prospective users to practice key steps in a low-pressure environment before attending formal training. By making the onboarding process more approachable, we believe these resources can help support patient confidence, adoption and retention." The tool is meant to complement, not replace, formal training provided by healthcare professionals or Modular Medical. This educational experience is not part of the FDA-required training program for the Pivot insulin delivery system. It is an optional educational resource designed to familiarize prospective users with the device and help gauge interest and readiness ahead of formal onboarding.
In addition:
“Healthcare providers may also use the platform to gauge a patient's interest in pump therapy and ability to navigate basic operational tasks associated with insulin delivery devices. The experience offers clinicians valuable insight into patient engagement, learning readiness, and willingness to transition from multiple daily injections to a more advanced insulin delivery approach.”
"Many patients who could benefit from pump therapy never take the first step because they perceive pumps as complicated," added Mr. Besser. "This interactive experience allows patients and providers to explore pump therapy in a risk-free environment, while helping identify individuals who may be ready to consider a pump."
Expanding Diabetes Education Through Gaming
“Modular Medical and Relevate Health Games are also launching a Pivot module inside Level One: A Diabetes Game, the free Type 1 diabetes education game developed and published by Relevate Health Games (formerly Level Ex) and available on the Apple App Store and Google Play. Since its launch in April 2025, Level One has been downloaded more than 53,000 times and is supported by leading Type 1 diabetes organizations, including Breakthrough T1D and Beyond Type 1.
Level One's core gameplay centers on one of the most challenging aspects of diabetes management: mealtime insulin dosing. Across dozens of bite-sized levels, players learn and test their understanding of bolus insulin delivery in relation to food intake, reinforcing concepts around carbohydrate counting, meal planning, and mealtime dosing decisions.
The new Pivot module builds directly on that foundation. Once players have mastered the fundamentals of mealtime dosing, they take on the same challenges with the Pivot pump, experiencing firsthand how the device fits into the dosing decisions they have already learned to make and how pump therapy can become a natural, helpful part of everyday diabetes care. The module is designed to educate users on concepts related to mealtime insulin therapy and does not provide individualized dosing recommendations or replace guidance from a healthcare professional.”
"Partnering with Modular Medical on the Pivot onboarding experience has been a pleasure, and the work matters. When pump therapy feels approachable, more patients and caregivers can access the care they need," said Amir Lotan, Group Vice President, Relevate Health Games. "We're proud of the impact Level One has already had on families in gaining confidence managing and living with Type 1 diabetes, and this collaboration extends the same philosophy to the device. Relevate Health Games' mission is to create positive change for patients and the healthcare providers who support them, and play is one of the most powerful tools we have to achieve it."
"Our vision extends beyond device innovation," added Mr. Besser. "We are committed to building practical educational tools that make advanced insulin therapy more approachable. By combining technology, education, and engagement, we believe we can help more people successfully transition to therapies that improve outcomes and quality of life."
We are continuing to monitor MODD for a sustainable breakout higher.
Sources: Presentation, PR1, PR2, PR3, PR4, PR5, PR6, PR7, PR8, PR9, PR10, PR11, PR12, PR13, PR14, Website, Chart
Happy Trading!
SmallCapStocks Team
Note: We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
DISCLAIMER:
You should read and understand this disclaimer in its entirety before joining the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated nine thousand dollars by bank wire transfer on 10/14/26 for the distribution of this advertisement about MODD dated 10/15/26. Previously, owners and operators of the Publisher have been compensated eight thousand dollars by bank wire transfer on 7/8/26 for the distribution of a prior advertisement about MODD. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
You are receiving this report/release because you subscribed to receive it at our website or through a third-party site. All our newsletters include an "unsubscribe" link, and you can remove yourself at any time from our newsletters by clicking on that "unsubscribe" link. You can also contact us at [email protected] to change your information at any time. By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link:
www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.